Nomura Holdings’s Moderna MRNA Stock Holding History

Nomura Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27M	Buy	+25,000	New	+$1.17M	﹤0.01%	1077
2025 Q4	–	Sell	-70,000	Closed	-$1.81M	–	2065
2025 Q3	$1.81M	Sell	70,000 -55,000	-44%	-$1.53M	﹤0.01%	1170
2025 Q2	$3.45M	Buy	+125,000	New	+$3.29M	0.01%	677
2024 Q3	–	Sell	-260,300	Closed	-$30.9M	–	1818
2024 Q2	$30.9M	Buy	+260,300	New	+$32.9M	0.06%	178
2024 Q1	–	Sell	-2,100	Closed	-$209K	–	1885
2023 Q4	$209K	Sell	2,100 -23,700	-92%	-$1.99M	﹤0.01%	1575
2023 Q3	$2.66M	Sell	25,800 -1,200	-4%	-$134K	0.01%	716
2023 Q2	$3.28M	Buy	27,000 +12,000	+80%	+$1.6M	0.01%	605
2023 Q1	$2.3M	Buy	+15,000	New	+$2.47M	0.01%	775
2022 Q4	–	Sell	-1,200	Closed	-$143K	–	1612
2022 Q3	$143K	Sell	1,200 -200	-14%	-$30.3K	﹤0.01%	1279
2022 Q2	$209K	Hold	1,400	–	–	﹤0.01%	1276
2022 Q1	$248K	Buy	1,400 +1,200	+600%	+$202K	﹤0.01%	1505
2021 Q4	$50K	Buy	+200	New	+$58.5K	﹤0.01%	2065
2020 Q4	–	Sell	-345,000	Closed	-$24.4M	–	1605
2020 Q3	$24.4M	Buy	+345,000	New	+$24.1M	0.05%	203

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings's MRNA Position: Q1 2026 in Review

Nomura Holdings increased its Moderna (MRNA) stake by 18% in Q1 2026, buying an estimated $283K and bringing the position to 40,543 shares worth $2.06M. The position accounts for 0.01% of the portfolio, ranked #918.

Nomura Holdings first reported a position in MRNA in Q3 2019 and has held it in 22 quarters since. The position peaked at $16M in Q2 2024. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Nomura Holdings held 40,543 shares of Moderna worth $2.06M as of Q1 2026.
Nomura Holdings bought 6,074 Moderna shares in Q1 2026, an estimated $283K.
Moderna made up 0.01% of Nomura Holdings's portfolio in Q1 2026, its #918 holding.
Nomura Holdings first reported a position in Moderna in Q3 2019 and has held it in 22 quarters since.
Nomura Holdings's Moderna position peaked at $16M in Q2 2024.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.